Similarly, CD24-CD44+ breast cancer stem cells (BCSCs) located at the tumor invasive frontier display a quiescent mesenchymal phenotype, while aldehyde dehydrogenase-positive (ALDH+) BCSCs distributed more centrally show a proliferative epithelial phenotype. Here, CD44 is linked to neoplasm.